These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1765 related articles for article (PubMed ID: 15297292)
1. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Grundy SM; Cleeman JI; Merz CN; Brewer HB; Clark LT; Hunninghake DB; Pasternak RC; Smith SC; Stone NJ; Arterioscler Thromb Vasc Biol; 2004 Aug; 24(8):e149-61. PubMed ID: 15297292 [TBL] [Abstract][Full Text] [Related]
2. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines. Grundy SM; Cleeman JI; Merz CN; Brewer HB; Clark LT; Hunninghake DB; Pasternak RC; Smith SC; Stone NJ; J Am Coll Cardiol; 2004 Aug; 44(3):720-32. PubMed ID: 15358046 [TBL] [Abstract][Full Text] [Related]
3. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Grundy SM; Cleeman JI; Merz CN; Brewer HB; Clark LT; Hunninghake DB; Pasternak RC; Smith SC; Stone NJ; ; ; Circulation; 2004 Jul; 110(2):227-39. PubMed ID: 15249516 [TBL] [Abstract][Full Text] [Related]
4. Recent National Cholesterol Education Program Adult Treatment Panel III update: adjustments and options. Stone NJ; Bilek S; Rosenbaum S Am J Cardiol; 2005 Aug; 96(4A):53E-59E. PubMed ID: 16098845 [TBL] [Abstract][Full Text] [Related]
5. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Cheng AY; Leiter LA Curr Opin Cardiol; 2006 Jul; 21(4):400-4. PubMed ID: 16755211 [TBL] [Abstract][Full Text] [Related]
6. Treatment of high-risk older persons with lipid-lowering drug therapy. Aronow WS Am J Ther; 2008; 15(2):102-7. PubMed ID: 18356628 [TBL] [Abstract][Full Text] [Related]
7. Reaching goal in hypercholesterolaemia: dual inhibition of cholesterol synthesis and absorption with simvastatin plus ezetimibe. Daskalopoulou SS; Mikhailidis DP Curr Med Res Opin; 2006 Mar; 22(3):511-28. PubMed ID: 16574035 [TBL] [Abstract][Full Text] [Related]
8. Effectiveness of the addition of ezetimibe to ongoing statin therapy in modifying lipid profiles and attaining low-density lipoprotein cholesterol goals in older and elderly patients: subanalyses of data from a randomized, double-blind, placebo-controlled trial. Pearson T; Denke M; McBride P; Battisti WP; Brady WE; Palmisano J Am J Geriatr Pharmacother; 2005 Dec; 3(4):218-28. PubMed ID: 16503317 [TBL] [Abstract][Full Text] [Related]
9. Cardiovascular risk reduction: what do recent trials with rosuvastatin tell us? Fabbri G; Maggioni AP Adv Ther; 2009 May; 26(5):469-87. PubMed ID: 19444394 [TBL] [Abstract][Full Text] [Related]
10. Rising to the challenge of treating high-risk patients. Guthrie RM Am J Manag Care; 2006 Oct; 12(11 Suppl):S318-24. PubMed ID: 17042674 [TBL] [Abstract][Full Text] [Related]
11. Efficacy of atorvastatin in achieving National Cholesterol Education Program low-density lipoprotein targets in women with severe dyslipidemia and cardiovascular disease or risk factors for cardiovascular disease: The Women's Atorvastatin Trial on Cholesterol (WATCH). McPherson R; Angus C; Murray P; Genest J; Am Heart J; 2001 Jun; 141(6):949-56. PubMed ID: 11376309 [TBL] [Abstract][Full Text] [Related]
12. Management of hypercholesterolemia in older persons for the prevention of cardiovascular disease. Aronow WS; Frishman WH Cardiol Rev; 2010; 18(3):132-40. PubMed ID: 20395698 [TBL] [Abstract][Full Text] [Related]
13. Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice. Harley CR; Gandhi S; Blasetto J; Heien H; Sasane R; Nelson SP Am J Geriatr Pharmacother; 2007 Sep; 5(3):185-94. PubMed ID: 17996658 [TBL] [Abstract][Full Text] [Related]
14. Pharmacologic options for aggressive low-density lipoprotein cholesterol lowering: benefits versus risks. McKenney JM Am J Cardiol; 2005 Aug; 96(4A):60E-66E. PubMed ID: 16098846 [TBL] [Abstract][Full Text] [Related]
15. Cholesterol: precursor to many lipid disorders. Jones PH Am J Manag Care; 2001 Aug; 7(9 Suppl):S289-98. PubMed ID: 11517815 [TBL] [Abstract][Full Text] [Related]
16. Management of dyslipidemia in the high-risk patient. Stein EA Am Heart J; 2002 Dec; 144(6 Suppl):S43-50. PubMed ID: 12486415 [TBL] [Abstract][Full Text] [Related]
17. [New results in the management of hypercholesterolemia]. Sármán B Orv Hetil; 2005 Sep; 146(39):1999-2004. PubMed ID: 16265867 [TBL] [Abstract][Full Text] [Related]
19. A summary of implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Grundy SM; Cleeman JI; Merz CN; Brewer HB; Clark LT; Hunninghake DB; Pasternak RC; Smith SC; Stone NJ; Arterioscler Thromb Vasc Biol; 2004 Aug; 24(8):1329-30. PubMed ID: 15297284 [No Abstract] [Full Text] [Related]
20. Effects of modifying triglycerides and triglyceride-rich lipoproteins on cardiovascular outcomes. Abdel-Maksoud M; Sazonov V; Gutkin SW; Hokanson JE J Cardiovasc Pharmacol; 2008 Apr; 51(4):331-51. PubMed ID: 18427276 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]